Japan Laws (Overview) — THC‑Free CBD 2025

This page offers a conservative, high‑level orientation to Japan’s approach to CBD, with emphasis on products marketed as “THC‑free.” It is not legal advice. Verify with Japan’s Ministry of Health, Labour and Welfare (MHLW), the Pharmaceuticals and Medical Devices Agency (PMDA), Customs, and the latest Cannabis Control Act and related guidance.

Snapshot

  • THC remains strictly prohibited. Products containing any detectable THC (including Δ9‑THC and often related precursors) are not permitted for consumer sale/possession.
  • CBD can be highly constrained. Policies have evolved, but permissibility depends on precise product composition, source materials, and compliance with current rules. Treat “THC‑free” as non‑detectable at stringent laboratory LOQs, not an allowance by itself.
  • Enforcement is active. Seizure or refusal at import is possible if paperwork is incomplete or tests indicate THC.

What “THC‑free” means in Japan (lab vs policy)

Commercial “THC‑free” claims refer to COAs reporting THC as Not Detected (ND) at the laboratory’s Limit of Quantitation (LOQ). In practice, Japanese authorities may scrutinize:

  • THC and THCA lines (and any other controlled cannabinoids) at very low LOQs.
  • Source materials (historically: specific plant parts and derivatives); confirm current requirements directly with MHLW.
  • Labeling and ingredient transparency consistent with submitted documentation.

Access and supply (high level)

  • Domestic retail: Retail availability depends on product type, composition, and evolving policy. Do not assume all “CBD” items are permitted.
  • Medical context: Certain prescription medicines (distinct from supplements) have separate pathways; this does not generalize to consumer CBD.

Import, customs, and retail reality

  • Personal import: Approach with caution. Requirements can include advance inquiries, detailed documentation of ingredients, manufacturing, and batch‑matched COAs showing ND THC at low LOQs. Even with paperwork, shipments can be refused.
  • Commercial import: Expect rigorous scrutiny. Use ISO/IEC 17025‑accredited labs, match labels to COAs, and clarify plant‑part sourcing and processing history. Engage qualified counsel or import specialists as needed.

Testing, labeling, and documentation

  • Use third‑party COAs (potency + contaminants) that clearly list Δ9‑THC, THCA, Total THC, LOQ values, method, and signatures.
  • Ensure batch identity on label matches the COA; provide ingredient lists and manufacturer contact details.
  • Favor simple formulas (e.g., CBD isolate or well‑documented broad‑spectrum) and avoid ambiguous flavor systems or added cannabinoids without COA support.

Travel

  • Do not assume you can enter Japan with CBD—even “THC‑free.” Possession may lead to seizure and potential penalties if the product is deemed non‑compliant.
  • Risk may extend to transit through airports. Many travelers choose not to carry CBD internationally.

See: International Travel Guidelines.

How to verify quickly

  1. Check official MHLW resources for current CBD/THC rules and definitions.
  2. Confirm a recent, batch‑matched COA with ND THC at low LOQs; ensure label↔COA alignment.
  3. When uncertain, avoid import/carry; consider obtaining permitted products in‑market via compliant channels.

Related resources

FAQ

Is CBD legal in Japan if it’s THC‑free?
Do not assume legality from a “THC‑free” label alone. Permissibility depends on current policy, composition, and documentation. Verify with MHLW.

Can I bring my CBD from abroad?
Personal import is risky and may be refused. Advance verification and precise paperwork are essential; many travelers avoid carrying CBD.

What LOQ should I look for?
Lower (more sensitive) LOQs provide stronger assurance. Use ISO/IEC 17025‑accredited labs and ensure Δ9‑THC, THCA, and Total THC are clearly reported.


Disclaimer: Educational only. Policies and enforcement change. Consult official sources and qualified professionals.